Evidence map›Paper›PMID 39886567›Full record

ArticleJACS Au2025

AshPhos Ligand: Facilitating Challenging Aminations in Five- and Six-Membered Heteroaryl Halides Using Cyclic Secondary and Bulky Amines.

Ashish Dusunge, David K Leahy, Sachin Handa

Abstract read
In one paragraph

Article in JACS Au, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ashish DusungeDepartment of Chemistry, University of Missouri, 601 South College Avenue, Columbia, Missouri 65211, United States.
David K LeahyBiohaven Pharmaceuticals, 215 Church Street, New Haven, Connecticut 06510, United States.ORCID https://orcid.org/0000-0003-4128-7792
Sachin HandaDepartment of Chemistry, University of Missouri, 601 South College Avenue, Columbia, Missouri 65211, United States.ORCID https://orcid.org/0000-0002-7635-5794

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Our newly developed AshPhos ligand represents a significant advancement in Buchwald-Hartwig aminations, overcoming many limitations of existing ligands. Created from affordable and accessible materials, AshPhos enhances catalytic performance, especially for extremely difficult substrates, by emphasizing the principles of ligand chelation and cooperativity. Its successful synthesis and application in catalytic aminations underscore its potential for use in the sustainable synthesis of compounds important to medicinal chemistry, materials, and energy. Further studies validated AshPhos's effectiveness in coupling challenging heteroaryl bromides and chlorides with various amines, including hindered amines and those with multiple heteroatoms. Slightly elevated temperatures were essential to avoid forming inactive species, ensuring consistent catalytic turnover. A control nuclear magnetic resonance spectroscopy study suggests the formation of catalytically dormant species or deligation of AshPhos from palladium at room temperature due to the coordination of multiple substrate molecules with the palladium species. Analyses showed cost-effectiveness of AshPhos, making it a significant advancement in catalytic amination for more efficient and sustainable chemical processes. The diverse substrate scope, covering challenging coupling partners and forming over 55 substrates in good-to-excellent yields, further demonstrated the efficiency of AshPhos.

Identifiers

PMID39886567
PMCPMC11775683

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.